Dexmedetomidine Enhancing the Recovery After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

January 31, 2025

Conditions
Post-cardiac Surgery
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine (DXM) loading dose of 0.6 µg/kg followed by DXM infusion given at a rate of 0.4 ml/kg/h and was provided as 0.15 µg/kg/h for 24-h PO.

DRUG

Fentanyl

A bolus of fentanyl 5 µg/kg followed by an intraoperative (IO) fentanyl infusion of 3-5 µg/kg/h that was continued as PO analgesia for 24 hours in a dose of 0.3 µg/kg/h.

DRUG

Lidocain

Lidocaine (LID) loading dose (1 mg/kg) followed by a continuous infusion till 24 h PO as 1.5 mg/kg/h.

Trial Locations (1)

13511

Benha University, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT06907277 - Dexmedetomidine Enhancing the Recovery After Cardiac Surgery | Biotech Hunter | Biotech Hunter